Results 101 to 110 of about 7,593 (192)

Preclinical characterization of 3p-C-DEPA_-NCS and 3p-C-DEPA_-TFP-PEG₄ as potential Actinium-225 bifunctional chelators using DOTA_-NCS and macropa_-NCS as benchmarks. [PDF]

EJNMMI Radiopharm Chem
Pougoue Ketchemen J, Ahenkorah S, Nwangele E, Malaza SSP, Ooms M, Cardinaels T, Leekens S, Cleeren F, Fonge H.   +8 more
europepmc   +1 more source

Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer. [PDF]

J Med Chem
Auvert E, Douez E, Jolivet L, Witkowski T, Jallas AC, Boursin F, Molnar I, Colas C, Wittmann SV, Auriol M, Chezal JM, Aubrey N, Allard-Vannier E, Maisonial-Besset A, Joubert N, Denevault-Sabourin C.   +15 more
europepmc   +1 more source

Harnessing Fc-Directed Bioconjugation for the Synthesis of Site-Specifically Modified Radioimmunoconjugates. [PDF]

Bioconjug Chem
Grimaldi C, Sebastiano J, Kao WM, Strugala E, McGlone SA, Watanabe T, Aoki T, Fujii T, Zeglis BM.   +8 more
europepmc   +1 more source

Cell death mechanisms induced by gold nano-immunoconjugates-mediated photodynamic therapy against human oesophageal cancer stem cells. [PDF]

Front Immunol
Didamson OC, Chandran R, Abrahamse H.
europepmc   +1 more source

In vitro evaluation of anti-HIV radioimmunoconjugates labeled with astatine-211, thorium-227 and actinium-225. [PDF]

Nucl Med Biol
Kuhlmann AS, Hamlin DK, Li Y, Wang X, Li L, Orvig C, Kiem HP, Sandmaier BM, Wilbur DS, Pincus S, Harrington RD.   +10 more
europepmc   +1 more source

Hepatocellular Carcinoma and Antibody Drug Conjugates: A Systematic Review. [PDF]

Cureus
Maddukuri S, Haddad RR, Battula NS, Chay T, Patel T, Dumaru N, Mohammed L.   +6 more
europepmc   +1 more source

It's a match: use of the radionuclide theranostic pair ¹³³La/²²⁵Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. [PDF]

EJNMMI Radiopharm Chem
Trommer J, Ullrich M, Reissig F, Brühlmann SA, Nitt-Weber AK, Novy Z, Hajduova K, Kurfurstova D, Hendrychova R, Bouchal J, Petrik M, Neuber C, Sihver W, Stadlbauer S, Pietzsch J, Kreller M, Kopka K, Mamat C, Zarschler K.   +18 more
europepmc   +1 more source

Old methods, lasting impact in relapsed/refractory primary mediastinal B-cell lymphoma. [PDF]

Haematologica
Ringelstein-Harlev S.
europepmc   +1 more source

J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of <i>Pseudomonas</i> Exotoxin A. [PDF]

Pharmaceuticals (Basel)
Pincus SH, Luo K, Peters T, Gordy JT, Cole FM, Klug G, Ober K, Marcotte TK, Markham RB.   +8 more
europepmc   +1 more source

Complete response following trastuzumab-deruxtecan in a man with HER2-overexpressing metastatic, poorly differentiated scrotal carcinoma. [PDF]

Oncologist
Hofstad M, Zheng J, Tachibana I, Zhang T.   +3 more
europepmc   +1 more source